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Magnetic nanoparticles (MNPs) have been popularly used in many fields. Recently, many kinds of MNPs are
modified as new absorbents, which have attracted considerable attention and are promising to be applied in waste
water. In our previous study, we synthesized two novel MNPs surface-coated with glycine or lysine, which could efficiently
remove many anionic and cationic dyes under severe conditions. It should be considered that MNP residues in water
may exert some side effects on human health. In the present study, we evaluated the potential nanotoxicity of MNPs
in human endothelial cells, macrophages, and rat bone marrow stromal cells. The results showed that the two kinds of
nanoparticles were consistently absorbed into the cell cytoplasm. The concentration of MNPs@Gly that could distinctly
decrease survival was 15 μg/ml in human umbilical vascular endothelial cells (HUVECs) or bone marrow stromal cells
(BMSCs) and 10 μg/ml in macrophages. While the concentration of MNPs@Lys that obviously reduced viability was
15 μg/ml in HUVECs or macrophages and 50 μg/ml in BMSCs. Furthermore, cell nucleus staining and cell integrity assay
indicated that the nanoparticles induced cell apoptosis, but not necrosis even at a high concentration. Altogether,
these data suggest that the amino acid-coated magnetic nanoparticles exert relatively high cytotoxicity. By contrast,
lysine-coated magnetic nanoparticles are more secure than glycine-coated magnetic nanoparticles.
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Nanoparticles have been used for many fields because of
their diversiform properties; meanwhile, growing concerns
for their detrimental effects on human health have been
taken to the agenda [1]. Nanoparticles based on iron oxide
core (so-called magnetic nanoparticles (MNPs)) have been
widely used in magnetic resonance imaging (MRI) [2-4],
drug delivery devices [5], and environmental pollutant
absorbents [6-9] for their superparamagnetic properties,
smaller size but large surface-to-volume ratio, and in-
creased reactivity. Emerging evidence has shown that* Correspondence: bxzhao@sdu.edu.cn; miaojy@sdu.edu.cn
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in any medium, provided the original work is pnanotoxicity to biological system is scale-dependent, es-
pecially in particles below 20-nm diameter [10]. How-
ever, the bare nanoparticles are often coated with kinds
of organic or other biological targeted materials, such as
dextran [11-13], which may greatly influence their toxicity
on multicellular organisms, increasing the complexity
for toxicology evaluation. The key challenge we are fa-
cing is to find an effective approach to design surface-
coated nanoparticles with enhanced functions as well as
high biocompatibility.
Increasing studies report that the materials surface-
coated with MNPs were intravenously administrated to
diagnose cardiovascular diseases (e.g., atherosclerosis)
and used for cancer therapy [6,11,14-17]. Once nano-
particles were administrated into the organism, they will
enter through the blood vessel wall and then participate
in blood circulation. Vascular endothelial cells lining thepen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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particles directly, which makes it considerably import-
ant to determine the nanotoxicity on vascular endothe-
lial cells [18].
MNPs coated with kinds of biological materials have
also been used as carriers for cell labelling [19,20]. Bone
marrow stromal cells (BMSCs), as very important cells
in the biological organism, act as sources of blood and
tissue reproduction and are extensively used in cell ther-
apy [21-24]. In the field of cell therapy, BMSC-derived
cells are marked with magnetic nanoparticles so as to
real-time resonance checking cells, which has got broad
prospects [25]. However, the fact that many magnetic
nanoparticles have the potential cytotoxicity on BMSCs
makes a major obstacle for their successful application. So
understanding the toxicity of the novel amino acid-coated
magnetic nanoparticles on BMSCs is highly necessary.
To date, several kinds of MNPs have also been approved
for disease detection by intraperitoneal injection [26,27]
as well as intravenous injection [28]. Therefore, there is
a wide range of interaction between macrophages and
nanoparticles, which results in macrophage activation
and causes subsequent inflammatory responses. Recent
studies hint that MNP-labeled macrophages can be used
for monitoring disease activity [29]. However, we still
have no idea about what concentration of nanoparticles
causes injury in macrophages. The human monocyte
cell line THP-1 can differentiate into macrophages after
phorbol-12-myristate acetate (PMA) stimulation, which
is regarded as a widely used model to study macrophage
function [30,31]. Therefore, in this study, we evalu-
ated the cytotoxicity of nanoparticles on THP-1-derived
macrophages.
Our previous studies showed that the MNP surface-
coated with lysine or glycine could efficiently remove
several kinds of anionic and cationic dyes under severe
conditions [8,9], so the two kinds of nanoparticles are
highly promising to be used in wastewater. However, we
do not know whether the residue in water may have det-
rimental effects on human and animal cells.
In the present study, we hypothesized that the amino
acid-coated MNPs might display some nanotoxicity in
human important cells, including vascular endothelial
cells and macrophages, and rat BMSCs. We made a
study on the nanotoxicity in the three kinds of cells:
human umbilical vascular endothelial cell (HUVECs),
BMSCs, and THP-1-derived macrophages. The goal of
this study was to detect the possible safe concentration
of MNPs (average diameter = 10 nm) on the cells. We
examined the nanotoxicity of the two kinds of MNPs by
assessing their effects on cell morphological changes,
viability, and apoptosis. These data suggest that the
amino acid-coated magnetic nanoparticles exert relatively
high cytotoxicity; by contrast, lysine-coated magneticnanoparticles are more secure than glycine-coated mag-
netic nanoparticles.
Methods
Preparation and characterization of two novel amino
acid-coated magnetic nanoparticles
Two kinds of Fe3O4 nanoparticles surface-coated with
glycine (MNPs@GLy) and lysine (MNPs@Lys) were
used in our experiments. The scheme for the synthesis
of the nanoparticles and the characterization data such
as transmission electronic microscope (TEM) images,
the structures, and Fourier transform infrared spectroscopy
measurements were determined as previously described by
Zhang et al. [8,9]. The hydrodynamic size, polydispersity
index, and zeta potential were detected by dynamic light
scattering (DLS) (Malvern Zetasizer Nano ZS90, Malvern
Instruments, Malern, UK). Since the bare Fe3O4 were
originally coated with 3-glycidoxypropyltrimethoxysilane
(GPTMS) and then were combined with glycine or lysine
through chemical bonds, it means that high temperature
cannot break the structure of MNPs. Thus, for our experi-
ments, the nanoparticles were first sterilized at 121°C for
30 min and then were suspended in M199 medium (for
HUVEC culture), Dulbecco's modified eagle's medium
(DMEM) (Gibco, Carlsbad, CA, USA) medium (for BMSC
culture) or RPMI1640 medium (for THP-1 culture). Stock
solutions (concentration of 2 mg/ml) were sonicated
for 10 min so as to break up the aggregates. Before each
experiment, the nanoparticles were sonicated again for
5 min and blown top and down 10 times to achieve
good suspension.
Cell culture
HUVECs were cultured as described by Jaffe et al. [32].
The cells were remained in M199 medium (Gibco), sup-
plemented with 15% fetal bovine serum (FBS) (Hyclone
Lab Inc., Logan, UT, USA) and 10 IU/ml FGF-2, and incu-
bated at 37°C incubation in humidified air with 5% CO2.
Experiments were performed on the cells from 10 to 20
passages.
BMSCs were isolated and cultured as described previ-
ously [33]. Briefly, the BMSCs were isolated from femur
and tibia marrows of 30-day-old neonatal male Wistar
rats; the isolated cells were cultured in DMEM (low glu-
cose), supplemented with 15% FBS (Hyclone Lab Inc.)
and 10 IU/ml FGF-2, and remained at 37°C in humidified
air with 5% CO2 incubator. Cells from 5 to 15 passages
were used in our experiments.
Both HUVECs and BMSCs were exposed to MNPs
after they were cultured for 24 h at the initial density of
1.5 × 104/cm2. THP-1 cells were cultured in RPMI 1640
medium (Gibco) and supplemented with 10% FBS
(Hyclone Lab Inc.) and 1% penicillin-streptomycin at 37°C
in humidified air with 5% CO2. For the experiments, the
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24-well plate and were stimulated with 100 ng/ml PMA
(Sigma-Aldrich, St, Louis, MO, USA) for 96 h so as to
be sufficiently differentiated into macrophages.
Prussian blue staining assay
To visualize the bio-distribution of MNPs in cells,
Prussian blue staining was performed according to manu-
facturer instruction. After cells were seeded in 24-well
plate for 24 h, the cells were incubated with two kinds of
MNPs (10 μg/ml) for 24 h. Then, the cells were fixed with
4% paraformaldehyde for 10 min, washed, and incubated
for 30 min with potassium ferric-ferrocyanide (reagent for
staining; Sigma). The cells were washed with running
water for 5 min, then were counterstained with nuclear
fast red. The pictures were taken under light microscopy
(Olympus, Nikon, Tokyo, Japan).
Cell viability assay
Cell viability was determined by using cell counting-8
(WST-8) kit (Sigma Chemical Co.). The detailed methods
were in compliance with manufacturer instruction. Briefly,
the cells were seeded in 96-well plate. The cells were
treated with nanoparticles for 44 h before 10 μl of WST-8
solution was added. After being blended in a micro-
oscillator, the cells were incubated for 4 h in 37°C incuba-
tor. In order to eliminate the interference of nanoparticles
on absorbance value, the aggregated particles were re-
moved by centrifugation at 1,500 rpm for 10 min. The OD
values were observed at 450 nm by microplate reader
(Tecan, San Jose, CA, USA).
Hoechst 33258 staining
Briefly, the cells were fixed with 4% paraformaldehyde
for 10 min after being washed with 1× PBS twice, then
incubated with Hoechst 33258 (Sigma) at a final con-
centration of 10 μg/ml for 15 min at 37°C incubator.
After the cells were washed with 1× PBS twice, digital
images were taken under a fluorescence microscope (Nikon
TE2000-U).
Acridine orange staining
The cells were stained with acridine orange (AO; 5 μg/ml)
(Fluka Chemical Corp., St. Louis, MO, USA) for 2 min
at room temperature, then washed with 1× PBS twice so
as to eliminate background interference. Dead cells
characterized with nuclear concentration and fragmenta-
tion was observed under a laser scanning confocal micro-
scope (Leica Microsystems, Wetzlar, Germany).
Acridine orange (AO) and ethidium bromide (EB) double
staining for THP-1-derived macrophages
Cell death (apoptosis or necrosis) was analyzed by meas-
uring the permeability of cell membrane with AO-EBstaining assay [34]. Because live cells are permeable to
AO but not to EB and stained green, and dead cells are
permeable to both AO and EB, and EB stained DNA
red, it is easier to determine apoptotic cells or necrotic
cells. Briefly, the cells were stained with cocktail of AO
(100 μg/ml) and EB (100 μg/ml) in RPMI 1640 medium
at 37°C for 10 min, then the cells were washed with PBS
twice. Digital images were taken with Olympus inverted
fluorescence microscope (Nikon TE2000-U).
Cell necrosis assay
Cell necrosis was determined by measuring the release
of lactic dehydrogenase (LDH); the assay was performed
using LDH kit (Nanjing Jiancheng Chemical Industrial
Co. Ltd., China) according to the manufacturer's instruc-
tion. The OD values were read at 440 nm using a micro-
plate reader (Tecan).
Statistical analysis
Data were expressed as mean ± SEM. The mean values
were derived from at least three independent experi-
ments. All statistical analyses were performed by using
GraphPad Prism software with the method of one-way
ANOVA (version 5; GraphPad Software Inc., San Diego,
CA, USA). Differences at P < 0.05 were considered statis-
tically significant.
Results and discussion
Physicochemical characteristics of two amino acid-coated
magnetic nanoparticles
In this study, we investigated the MNPs coated with two
kinds of amino acids (Gly or Lys). The physicochemical
information of the nanoparticles was listed in Additional
file 1: Table S1. In order to describe the hydrodynamic
size, dispersity, and the surface charge of nanoparticles,
we carried out the tests by DLS in different media and
concentrations. The glycine-coated MNPs at a low con-
centration exert a mean hydrodynamic size of about
200 nm in water and M199 culture but have an increase
of size at a high concentration. Similarly, the lysine-coated
MNPs have a mean hydrodynamic size of about 280 nm
in water, about 200 nm at a low concentration, while
about 340 nm at a high concentration in M199 culture.
Both particles remained a relatively good dispersity and
negative charge.
Since the cell culture contains a variety of proteins from
serum, the nanoparticles may interact with kinds of
protein through electrostatic interaction and adsorption
effect. Possible aggregations of nanoparticles make it diffi-
cult to assess the nanotoxicity. In order to directly explain
the dispersity of nanoparticles in culture medium, two of
the nanoparticles at different concentrations were incu-
bated with DMEM-L for 48 h; then, pictures were taken
to observe the dispersion of nanoparticles. We found no
Figure 1 The dispersion of two kinds of MNPs in the culture medium. DMEM-L supplemented with 15% FBS incubated with nanoparticles at
different concentrations. (A-E) MNPs@GLy and (F-J) MNPs@Lys.
Figure 2 Bio-distribution of two kinds of MNPs in cells. The two kinds of amino acid-coated nanoparticles were absorbed in cells and dispersed
in the cytoplasm. (A-C) HUVECs, (D-F) BMSCs, (G-I) macrophages. (A, D, G) Cells under normal conditions. (B, E, H) Cells were incubated with
MNPs@Gly and (C, F, I) incubated with MNPs@Lys.
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Figure 3 Effects of MNPs@Gly on HUVECs. (A) Morphological observation of HUVECs treated with MNPs@Gly for 6 h (×200), 24 h (×200), and
48 h (×100) at different concentrations. (B) Hoechst 33258 staining (top) and acridine orange staining (middle) for HUVECs treated with the
nanoparticles for 24 h. Hoechst 33258 staining for HUVECs treated with the nanoparticles for 48 h (bottom). Arrows indicated the dead cells. (C)
WST-8 assay determined the viability of HUVECs treated with the nanoparticles for 48 h at different concentrations (*P < 0.05, **P < 0.01,
***P < 0.001 vs normal, n = 3). (D) LDH assay detected no cell necrosis. Data were expressed as relative level of LDH compared with normal (n = 3).
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results further indicate a good dispersity of nanoparticles.
Supplementary physical or chemical information about
MNPs@Lys and MNPs@Gly could be found in [8,9], re-
spectively. The bio-distribution of the two kinds of
nanoparticles in cells were analyzed by Prussian blue
staining. Iron oxide nanoparticles could specially appear
blue by Prussian blue staining [27]. In our study, we
found that both nanoparticles were similarly absorbedinto the cytoplasm; the blue stained nanoparticles were
obviously distributed around the nucleus (Figure 2).
Nanoparticles have no interference on the colorimetric
assays for the detection of cell proliferation
In our study, cell viability was determined by colorimet-
ric assay between the cell supernatant and WST-8 kit.
Since in previous studies we found that both the glycine-
and lysine-coated nanoparticles could adsorb kinds of
Figure 4 Effects of MNPs@Lys on HUVECs. (A) Morphological observation of HUVECs treated with MNPs@Lys. (B) Hoechst 33258 staining (top)
and acridine orange staining (middle) after 24 h. Hoechst 33258 staining after 48 h (bottom). Arrows indicated the dead cells. (C) WST-8 assay
determined the viability of HUVECs treated with the nanoparticles for 48 h at different concentrations (**P < 0.01, ***P < 0.001 vs normal, n = 3).
(D) LDH assay detected no cell necrosis (n = 3).
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on the colorimetric assays makes it unavailable to detect
the cell proliferation accurately. To evaluate the poten-
tial interaction, after color reaction between the cell
supernatant with WST-8 kit, 50 μg/ml MNPs@Gly and
MNPs@Lys were incubated with cell supernatant at 37°C
for 60 min. Then, the optical density (OD) values were
observed after the nanoparticles were removed by cen-
trifugation. As shown in Additional file 1: Figure S1, for
the cases of normal culture and starvation, both nano-
particles did not interfere the OD values of cell viability.These data indicate that the WST-8 kit is able to detect
cell proliferation.
Cell morphological and viability changes of HUVECs
treated with the nanoparticles
Vascular endothelial cells were the first biological bar-
riers when nanoparticles were phagocytized through the
blood vessels [18]. In this study, we used HUVECs to
mimic the nanoparticle-endothelial interactions. To de-
termine the toxic concentration of the two kinds of
nanoparticles in HUVECs, the cells were incubated with
Figure 5 Effects of MNPs@Gly on BMSCs. (A) Morphological changes of BMSCs were observed under a phase contrast microscope after the
cells were treated with different concentrations of the nanoparticles for 24 h (×100) and 48 h (×100), respectively. (B) Changes of the cell nucleus
by Hoechst 33258 staining assay after the cells were treated with nanoparticles for 24 and 48 h at different concentrations. (C) Cell viability of
BMSCs treated with different concentrations of nanoparticles for 48 h by WST-8 assay. These data were presented as percentage compared with
the normal group (*P < 0.05, **P < 0.001 vs normal, n = 4). (D) Relative level of LDH released from BMSCs; the BMSCs were treated with the
nanoparticles for 48 h (n = 3).
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to 100 μg/ml) for 6, 24, and 48 h, respectively. The im-
ages showed that both MNPs@GLy and MNPs@Lys
were distinctly absorbed into cells and dispersed in the
cytoplasm as early as 6 h. We clearly found that the nano-
particles accumulated at 50 μg/ml. Moreover, both of them
were further swallowed after being incubated for 24 and
48 h. The images also indicated that the nanoparticles in-
duced increasing cell death in a concentration-dependent
manner but with no disturbance of cell membrane integ-
rity (Figures 3A and 4A). This was consistent with the re-
sults of Hoechst 33258 and AO staining which showed
relatively more nucleus condensation or fragments at rela-
tively high concentration (25 and 50 μg/ml) (Figures 3B
and 4B). WST-8 assay indicated that both glycine- andlysine-coated nanoparticles significantly reduced cell
viability at 15 μg/ml (Figures 3C and 4C).
Effects of the nanoparticles on morphology and viability
of BMSCs
We used the same methods as above to determine the
nanotoxicity in BMSCs. To our surprise, the MNPs were
not obviously phagocytized by BMSCs as HUVECs. More-
over, the MNPs obviously resulted in cell loss at higher
concentrations (25 and 50 μg/ml) (Figures 5A and 6A).
Then, we examined cell apoptosis by Hoechst 33258
staining. We clearly found cell nucleus condensation
or fragments after incubation with MNPs at higher
concentrations (more than 25 μg/ml) (Figures 4B and 5B).
WST-8 assay indicated that MNPs@Gly potently decreased
Figure 6 Effects of MNPs@Lys on BMSCs. (A) Morphological changes of BMSCs were observed under a phase contrast microscope after
treatment with different concentrations of the nanoparticles for 24 h (×100) and 48 h (×100), respectively. (B) Changes of the cell nucleus by
Hoechst 33258 staining assay after the cells were treated with the nanoparticles for 24 and 48 h at different concentrations. (C) Cell viability of
BMSCs treated with different concentrations of the nanoparticles for 48 h by WST-8 assay. These data were presented as a percentage compared
with the normal group (**P < 0.001 vs normal, n = 4). (D) Relative level of LDH released from BMSCs; the BMSCs were treated with the nanoparticles for
48 h (n = 3).
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cell viability at a concentration of 50 μg/ml (Figures 5C
and 6C).
Effects of the nanoparticles on morphology and viability
of THP-1-derived macrophages
To examine the cytotoxicity of the MNPs on macrophages,
we initially used PMA to differentiate THP-1 into macro-
phages. After the exposure of the cells to nanoparticles for
24 or 48 h, we found that the nanoparticles were dramat-
ically swallowed (Figures 7A and 8A). Meanwhile, AO-EB
staining indicated that the nanoparticles caused remark-
ably nucleus condensation. But the red-stained cell nu-
cleus was not found (Figures 7B and 8B), which wereregarded as cell necrosis. These results showed that
glycine-coated nanoparticles led to dramatic cell loss at 10
μg/ml, while lysine-coated nanoparticles decreased cell
viability at 15 μg/ml (Figures 7C and 8C).MNPs did not induce cell necrosis
LDH as a cytoplasmic enzyme can be released to the
extracellular space and could be detected distinctly in the
supernatant when cell membrane integrity is damaged.
Therefore, LDH is detected as a typical marker of cell
necrosis [35]. We found no difference in LDH release in
HUVECs (Figures 3D and 4D), BMSCs (Figures 5D and 6D),
and THP-1-derived macrophages (Figures 7D and 8D)
Figure 7 Effects of MNPs@Gly on macrophages. (A) Effects of the nanoparticles on cell morphology of THP-1-derived macrophages exposed
to the nanoparticles at different concentrations for 24 and 48 h. (B) Cell apoptosis or necrosis was determined by AO and EB double staining
assay. (C) Cell viability was determined by WST-8 assay; the cells were treated with the nanoparticles for 48 h (**P < 0.01, ***P < 0.001 vs normal,
n = 3). (D) Cell necrosis was determined by detecting the release of LDH from THP-1-derived macrophages (the cell density was
40,000/cm2, n = 3).
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for 48 h.
MNPs, owing to their large surface area, high separ-
ation efficiency, and low cost [7], have attracted great
interest as potential biophysical absorbents. Although
more concerns have been raised about the possible detri-
mental effects of MNPs on human health, the existing
information of nanotoxicity on different kinds of cells is
still incomplete. In this study, we used HUVECs (as the
first and the most important vascular barrier), BMSCs
(as one of the most important cells in organizing the
hematopoietic system), and macrophages (as a represen-
tative of inflammatory response cells) to evaluate the
toxicity of two novel amino acid-coated magnetic nano-
particles. Our previous studies reported that the novel
negative surface-charged Fe3O4 magnetic nanoparticles(Fe3O4@APS@AA-co-CA) could effectively remove heavy
metal ions and cationic dyes from aqueous solution [7,36].
The nanoparticles have no influence on the survival of
HUVECs until at a high concentration (400 μg/ml).
However, the two novel amino acid-coated MNPs
(MNPs@GLy and MNPs@Lys), by contrast, have severe
damage on HUCECs, BMSCs, and THP-1-derived macro-
phages, which decreased cell viability at a very low con-
centration (10 or 15 μg/ml). It has been reported that the
nanotoxicity may be size-dependent [37] and surface
charge-dependent [38], so big different toxicological im-
plications could be attributed to the contribution of
nanoparticle size as well as different surface charge. The
diameter of Fe3O4@APS@AA-co-CA is about 15 to 20 nm,
which is larger than the nanoparticles in the present study;
a smaller particle size may lead to more serious cytotoxicity
Figure 8 Effects of MNPs@Lys on macrophages. (A) Effects of the nanoparticles at different concentrations on cell morphology of THP-1-
derived macrophages treated for 24 and 48 h. (B) Cell apoptosis or necrosis was determined by AO and EB double staining assay. (C) Cell viability
was determined by WST-8 assay; the cells were treated with the nanoparticles for 48 h (**P < 0.01, ***P < 0.001 vs normal, n = 3). (D) Cell necrosis
was determined by detecting the release of LDH from THP-1-derived macrophages (the cell density was 40,000/cm2, n = 3).
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face charge. These factors may affect the interaction be-
tween the nanoparticles and cell membrane, which also
leads to the influence of cellular uptake of nanoparticles.
Our data further demonstrated that both the nanoparti-
cles were swallowed into cells in a time-dependent and
concentration-dependent manner. The nanoparticles were
constantly absorbed until the presence of aggregates of
nanoparticles.
One important implication of our findings is that the
same core nanoparticles coated with different materials
may display different nanotoxicity. Biomaterial (e.g., amino
acid or peptide)-modified nanoparticles do not necessarily
improve the biocompatibility of nanoparticles; these modi-
fied nanoparticles, on the contrary, may more easily inter-
act with cell membrane, which contributes to the uptakeof nanoparticles and results in greater cytotoxicity. Also,
we provide new evidence about the cell type-specific
nanotoxicity of amino acid-coated magnetic nanoparticles.
Conclusions
In summary, we evaluated the potential nanotoxicity of
two novel MNPs surface-coated with glycine or lysine in
human endothelial cells, macrophages, and rat bone
marrow stromal cells. These data suggest that the amino
acid-coated magnetic nanoparticles exert relatively high
cytotoxicity; lysine-coated magnetic nanoparticles are
more secure than glycine-coated magnetic nanoparti-
cles. Therefore, it should be cautious to apply the two
nanoparticles in wastewater treatment. Our findings may
provide useful information for the further design of iron
oxide nanoparticles.
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